Open AccessAssociation of Central Nervous System Depression With Topical Brimonidine When Used for Hemostasis
Author(s) -
Devorah Shagalov,
Drew Taylor,
Rachel Schleichert,
Jonathan Weiss,
Eduardo Weiss
Publication year - 2017
Publication title -
jama dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.128
H-Index - 166
eISSN - 2168-6084
pISSN - 2168-6068
DOI - 10.1001/jamadermatol.2017.0247
Subject(s) - brimonidine , medicine , hemostasis , depression (economics) , dermatology , anesthesia , ophthalmology , surgery , intraocular pressure , economics , macroeconomics
Minor bleeding is the most common complication of dermatologic surgery. Topical brimonidine, 0.33%, gel has been reported for the use of hemostasis in dermatologic surgery. The safety profile and risk of systemic toxic effects when brimonidine is used topically for hemostasis is unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom